Regional sympathetic blockade in primary fibromyalgia

Area of Science:

• Neurology
• Pain Management
• Autonomic Nervous System Research

Background:

• Primary fibromyalgia is a chronic pain condition.
• The role of the sympathetic nervous system in fibromyalgia is not fully understood.
• Autonomic dysfunction may be implicated in fibromyalgia symptoms.

Purpose of the Study:

• To investigate the effect of sympathetic blockade on fibromyalgia symptoms.
• To evaluate the efficacy of stellate ganglion blockade and guanethidine blockade in reducing pain and tender points.
• To explore the potential contribution of sympathetic activity to fibromyalgia pathogenesis.

Main Methods:

• Twenty-eight primary fibromyalgia patients participated.
• Stellate ganglion blockade with bupivacaine was administered.
• Intravenous regional guanethidine blockade was performed.
• Control groups received sham injections.
• Outcomes measured included skin blood flow, temperature, conductance, tender points, and pain levels.

Main Results:

• Complete sympathetic blockade via stellate ganglion blockade significantly reduced tender points and rest pain.
• Guanethidine blockade reduced tender points but did not affect rest pain.
• Improvements in pain and tender points correlated with sympathetic blockade.

Conclusions:

• Sympathetic blockade, particularly stellate ganglion blockade, effectively alleviates fibromyalgia pain and tender points.
• Sympathetic nervous system activity may play a role in the pathogenesis of primary fibromyalgia.
• Improved microcirculation could be a mechanism underlying pain reduction.